Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Mersana Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 8:56 pm Purchase | 2023-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | Venrock Healthcare Capital Partners III, L.P. | 11,328,000 9.400% | 1,650,000 (+17.05%) | Filing |
| 2023-08-07 4:15 pm Purchase | 2023-07-28 | 13G | Mersana Therapeutics, Inc. MRSN | Venrock Healthcare Capital Partners III, L.P. | 9,678,000 8.500% | 9,678,000 (New Position) | Filing |